Fredun Pharmaceuticals Ltd — Important, 08-06-2026: Company Update

Date: June 08, 2026

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015 ("SEBI Listing Regulations").

Dear Sir/Madam,

Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you that in

compliance with the provisions of Regulation 36(1)(b) of the SEBI Listing Regulations, letters are

being sent to those Members whose e-mail addresses are not registered with

Company/Registrar & Share Transfer Agent/Depository Participants, providing the exact

path/weblink of Company's website from where the Annual Report for FY 2025-26 and the

Notice convening the 39th Annual General Meeting of the Company can be accessed. A copy of the

said letter is enclosed for your record as Annexure 1.

Kindly take the same on record.

Thanking you,

Yours Sincerely,

For FREDUN PHARMACEUTICALS LIMITED

FREDUN MEDHORA

MANAGING DIRECTOR AND CFO

DIN: 01745348

Encl: a/a

To

The Assistant Manager

Listing Compliance,

BSE Limited,

P. J. Towers, Dalal Street,

Mumbai- 400 001.

Scrip Code: 539730

----------------Page (0) Break----------------

Date: June 08, 2026

To Shareholders,

Subject: Notice of 39th Annual General Meeting (AGM) of Fredun Pharmaceuticals Limited (the Company) and Annual

Report for the Financial Year 2025-26

We are pleased to inform you that 39th Annual General Meeting (the AGM/ the Meeting) of the Members of the Company is

scheduled to be held on Tuesday, 30th June, 2026, at 9:00 am (IST) through Video Conferencing ('VC') facility / Other Audio

Visual Means ('OAVM').

As per Regulation 36 (1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ( the SEBI

Listing Regulations, 2015), as amended, the web-link, including the exact path, where complete details of the Annual Report

are available is required to be sent to those Member(s) who have not registered their email address(es) either with the

Company or with any Depository or Purva Sharegistry (India) Private Limited, Registrar & Share Transfer Agent (RTA) of the

Company.

Accordingly, the web-link, including the exact path where complete details of the Annual Report for the Financial Year 2025-26

are available at:

http://www.fredungroup.com/investor-annual-report.html#investor

Website: http://www.fredungroup.com/investor-annual-report.html#investor

This letter is being sent to those Member(s) who have not registered their email address (es) either with the Company or with

any Depository or RTA of the Company as on the cut-off date as on Friday, 29th May, 2026.

This is also a reminder to update KYC details pursuant to SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37

dated May 07, 2024, and to dematerialize physical securities. The circular issued by SEBI mandates all the listed companies to

record PAN, Address with PIN code, Mobile Number, Bank Account details, Specimen Signature and choice of Nomination of

security holders, holding securities in physical mode. While updating Email ID is optional, the security holders are requested to

register email id also to avail online services. This is applicable for all security holders holding securities in physical mode.

The formats for choice of Nomination and Updation of KYC details viz; Forms ISR-1, ISR-2, ISR-3, SH-13, SH-14 and SEBI

circulars are available on our website, http://www.fredungroup.com/ or on the website of RTA i.e. Purva Sharegistry (India)

Pvt. Ltd. on https://purvashare.com/faq.

The aforesaid SEBI Circular also mandates that security holders holding in physical mode whose folios do not have PAN, Choice

of Nomination, contact details, Bank Account details and Specimen Signature updated, shall be eligible for any payment

including dividend, interest or redemption payment in respect of such folios, only through electronic mode with effect from

April 1, 2024.

Should you have any queries, please feel free to contact our investor relations department at Purva Sharegistry (India) Private

Limited at e-mail support@purvashare.com. Further shareholder queries or service requests in electronic mode are to be

raised only through the website, the link for which is https://purvashare.com/investor/login/ or 022 4134 3255 / 56.

Moreover, you are also requested to update your e mail address at the earliest either through your depository participants for

electronic holding or send a communication to us / our RTA to facilitate the updation to continue receiving all important

information & documents thereafter and encourage Green Initiative.

Thanking you,

Yours faithfully,

For Fredun Pharmacueticals Limited

Sd/-

Fredun Nariman Medhora

Managing Director & CFO

DIN: 01745348

----------------Page (1) Break----------------